
AI Fund Closes Oversubscribed $190 Million Fund II to Co-Found AI Startups
Venture studio expands its mission to work with entrepreneurs to build AI startups, providing hands-on support and early-stage funding to solve real-world challenges.
AI Fund , the venture studio founded by renowned AI pioneer and entrepreneur Andrew Ng, today announced the successful closing of its second fund, raising approximately $190 million in an oversubscribed round. This builds on the success of the studio's first $175 million fund and reflects the growing demand for AI-driven innovation across industries.
"AI technology advances over the past few years are creating a golden age for founding startups," said Ng, Managing General Partner. "With AI technology giving us increasingly better building blocks for developing software, plus the cost of prototyping plummeting because of AI assisted coding, we can create new startups faster and more efficiently than was ever possible before."
A High-Impact Model for Building AI Startups
AI Fund's venture studio model gives entrepreneurs a distinct advantage by combining deep AI expertise, market validation, and hands-on talent acquisition support. From ideation to launch, the studio partners with 0-to-1 entrepreneurs to shape the vision, build products, and assemble top-tier technical and leadership teams. This approach fast-tracks AI-powered solutions to market.
Under Ng's leadership, AI Fund works alongside entrepreneurs to build companies focused on the application and software infrastructure layers of the AI stack, leveraging foundation models to develop solutions across multiple sectors. The studio's portfolio includes ventures in financial services, renewable energy, future of work, education, logistics, healthcare, and developer tools.
Backing from Global Corporations
AI Fund's latest fundraise attracted a number of corporate limited partners (LPs), including The AES Corporation; HP Inc.; Mitsui & Co., Ltd.; Mitsubishi Corporation; QBE; and TELUS Global Ventures; among other notable venture capital investors such as Sequoia Capital and NEA. These corporate LPs are among the leaders in their industries that span technology, energy, financial services, healthcare, industrials, and real estate. AI Fund's corporate LPs have a global presence, with operations spanning nearly every continent.
The participation of these global corporate partners not only signals confidence in AI Fund's approach, but also reflects the collaborative foundation on which many of the fund's most promising ventures are built:
"Many of our ideas originate from close collaborations with corporate partners and VCs who identify critical gaps in their industries, allowing us to launch businesses with built-in customers, proprietary data sets, and market traction," said Warren Packard, Partner at AI Fund. "By bringing together corporate insights and entrepreneurial energy, we create companies that are positioned for long-term success."
"We believe AI Fund has a clear eye for what's next, and the ability to turn bold ideas into high-impact ventures," said Carmen Chang, Partner and Head of Asia, NEA. "As returning investors, we've seen how their model gives founders an edge in a fast-moving and increasingly competitive AI market. We're excited to continue supporting Andrew Ng and the team as they help shape the future of AI and its real-world impact."
"The next wave of AI innovation won't just be about breakthroughs in technology-it will be about how we build, scale, and apply those breakthroughs," said Andrés Gluski, CEO of The AES Corporation, "AI Fund is cultivating the kind of entrepreneurial rigor and technical depth needed to shape solutions that matter. We're excited to partner with AI Fund on a model that pairs visionary thinking with real-world execution."
"At HP, we are on a mission to create meaningful AI experiences that drive growth and more fulfilling work experiences for people everywhere," said Enrique Lores, President and CEO, HP Inc. "Our investment in AI Fund reflects our dedication to catalyzing the development of new experiences that allow users to benefit from AI at the edge. By supporting software innovators and startups, we aim to foster the entrepreneurial spirit needed to develop impactful AI solutions that will shape the future of work."
Investing in the Future of AI
AI Fund has been building AI startups since long before the widespread rise of tools like ChatGPT and the recent AI boom. With its latest fund, it will continue co-founding companies that leverage the latest technologies like agentic AI, reasoning models, and multi-modal AI.
"AI Fund is oriented to moving fast in how we build companies," said Ng. "Building startups is hard, and by systematically approaching the many steps of early stage startup building, such as ideation, having customer conversations, prototyping, product and engineering work, recruiting elite talent, acquiring capital, and so on, we minimize bottlenecks and help companies go much faster."
For more information, visit https://aifund.ai/ .
ABOUT AI FUND:
AI Fund is a venture studio that strives to move humanity forward by accelerating the adoption of AI. We work with entrepreneurs to build companies rapidly and increase their odds of success. The studio is supported by top-tier VCs and partners including Sequoia Capital, NEA, AES, and Nikkei. Learn more at https://aifund.ai/ .
MEDIA CONTACT:
Lauren Gill, MAG PR at E: lauren@mooringadvisorygroup.com ; P: 978-473-1362
# # #
SOURCE: AI Fund

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
36 minutes ago
- Yahoo
SoundHound AI Vs. BigBear.ai: Which Stock Is the Better Buy?
Shares of SoundHound AI, Inc. SOUN and Holdings, Inc. BBAI have soared 182.2% and 423.7% over the past year due to the rapid growth of artificial intelligence (AI). Let's explore which of these AI stocks investors should prioritize for future returns. SoundHound AI reported first-quarter revenues of $29.1 million, a 151% increase year over year. SoundHound AI anticipates 2025 revenues of $157 million to $177 million, up from last year's $84.7 million. SoundHound AI's 2024 booking backlog of $1.2 billion suggests strong long-term revenue growth, alongside a total addressable market (TAM) of $140 billion, indicating potential for further expansion. Demand for SoundHound AI's voice solutions is growing due to their efficiency and automation benefits. The conversational AI market is projected to grow from $17.05 billion in 2025 to $49.80 billion by 2031, per marketsandmarkets, offering opportunities for increased customer acquisition. Rising customer demand for quick service and labor shortages are driving restaurants to adopt voice automation, benefiting SoundHound AI, which now counts Casey's General Stores, Inc. CASY and Chipotle Mexican Grill, Inc. CMG among its clients. Finally, if trade tensions ease, SoundHound AI's overseas costs, particularly in China, will decrease, benefiting its bottom line. AI shipbuilding software supports U.S. Navy submarine construction, and its facial recognition technology is used in airport security. The company reported $34.8 million in first-quarter revenues, a 5% year-over-year increase. For the full year, expects revenues to increase to $160-$180 million. In 2025, experienced leadership changes, with Kevin McAleenan becoming CEO in January and the CFO departing in June; McAleenan's prior role as U.S. Homeland Security Secretary may aid in securing government contracts. Despite revenue growth, SoundHound AI and are unprofitable, with losses of $188 million and $62 million in the past 12 months and the first quarter, respectively. adjusted EBITDA worsened from -$1.6 million to -$7 million due to increased R&D spending. However, SoundHound AI's first-quarter revenue growth significantly outpaces with a robust balance sheet showing negligible debt, total assets of $587.5 million, and $245.8 million in cash exceeding total liabilities of $190.5 million. On the other hand, had total liabilities of $198.5 million in the first quarter, including $100.6 million in long-term debt. weak sales growth and balance sheet hinder profitability, while SoundHound AI's strong sales and healthy balance sheet suggest profitability by the end of 2025. Moreover, relies heavily on federal contracts, making it vulnerable to cuts, while SoundHound AI is less exposed to such risks, making it a better AI investment choice. Having said that, backlog rose 30% year over year to $385 million in the first quarter, fueled by new government contracts, indicating potential growth and investment opportunity. Currently, each of the stocks has a Zacks Rank #3 (Hold). You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Chipotle Mexican Grill, Inc. (CMG) : Free Stock Analysis Report Casey's General Stores, Inc. (CASY) : Free Stock Analysis Report Holdings, Inc. (BBAI) : Free Stock Analysis Report SoundHound AI, Inc. (SOUN) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
43 minutes ago
- Yahoo
MicroStrategy (NasdaqGS:MSTR) Launches US$4 Billion Preferred Stock Follow-On Offering
MicroStrategy saw a significant price move of 70% over the last quarter. This surge comes amidst a series of developments, notably the follow-on equity offering of $4.2 billion in preferred stock. Although the market itself showed strength as the S&P 500 and Nasdaq reached record highs, other events likely influenced MicroStrategy's performance. These include its addition to the Russell Top 200 Indexes and the launch of AI-focused product Strategy Mosaic™. Meanwhile, broader tech sector trends were mixed, with some stocks experiencing losses amidst potential geopolitical concerns, which may have also affected investor sentiment. Every company has risks, and we've spotted 1 warning sign for MicroStrategy you should know about. AI is about to change healthcare. These 25 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early. MicroStrategy's total shareholder return over the past five years was very large, reflecting remarkable performance. This significant long-term return contrasts with recent market trends, as the company showed superior performance by exceeding the US Market and the Software industry over the past year. Despite geopolitical influences affecting broader sentiment, MicroStrategy's inclusion in the Russell Top 200 Index and the launch of its AI product, Strategy Mosaic™, mark critical developments potentially influencing future prospects. The 70% share price surge over the last quarter puts the current price in context with consensus analyst price targets, which are over 20% higher than current levels. This suggests market optimism about future growth, though analysts are not in a statistically confident range of agreement. The effect of recent equity offerings and the substantial $4.22 billion net loss reported in Q1 2025 may impact the company's revenue and earnings forecasts. Investors will be keenly observing whether these initiatives will translate into sustainable long-term profitability and whether upcoming earnings growth aligns with or diverges from current industry trends. Our expertly prepared valuation report MicroStrategy implies its share price may be too high. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include NasdaqGS:MSTR. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
an hour ago
- Yahoo
NYB.AI and Pnaseer Inc. Announce Strategic Partnership to Apply AI in Hair Follicle Regeneration Research
SINGAPORE, July 08, 2025--(BUSINESS WIRE)-- and Pnaseer Inc. (Pnaseer) have announced a strategic partnership to accelerate the discovery of compounds that promote hair follicle regeneration using artificial intelligence (AI). The collaboration combines AI-powered compound screening capabilities with Pnaseer's proprietary bio-nanoparticle drug delivery platform to enhance therapeutic efficacy. CEO, Giang Nguyen, and Pnaseer's Global Business Development Director, Dr Shin Sung Min signed the agreements to deepen the cooperation between the two companies. The partnership centers on Project Follica, an initiative aimed at identifying and optimizing both natural and synthetic compounds that stimulate hair growth. will lead the development of advanced AI models to analyze extensive compound libraries, while Pnaseer will focus on formulating delivery systems that maximize the bioavailability and targeting precision of promising candidates. proprietary AI technology enables rapid prediction of compound-target interactions in hair biology, significantly accelerating early-stage discovery. Pnaseer's delivery platform ensures optimal formulation and distribution of actives to target tissues, paving the way for scientifically validated hair restoration solutions. Project Follica aims to deliver a transformative impact through three key outcomes. First, it will build an AI-informed database of natural and synthetic compounds, mapped to critical biological pathways involved in hair follicle regeneration. Second, the collaboration will develop a scientifically validated, formulation-ready prototype for preclinical evaluation and future product development. Third, the project will create a scalable AI discovery framework tailored for dermatological and regenerative medicine applications. "With Project Follica, we are not only accelerating compound discovery but also redefining how the industry approaches hair regeneration. The combination of AI and deep biological insights allows us to uncover promising bioactives that were previously overlooked," said Giang Nguyen, CEO, "Hair regeneration requires a highly targeted, multidisciplinary approach. By combining NYB's AI insights with our advanced delivery technology, we aim to unlock novel solutions that can overcome current limitations in efficacy and safety," said Dr Shin Sung Min, Co-Founder & Global Business Development Director, Pnaseer Inc. The collaboration includes comprehensive validation through in silico simulations, in vitro assays, formulation optimization, and preclinical readiness. Both parties will share critical research resources, including compound databases, biological data, and AI tools, to ensure scientific rigor and project efficiency. About Pnaseer Inc: Pnaseer Inc. is a biotech firm focused on advanced drug delivery tech. It enhances approved drugs' performance using its proprietary bio-nanoparticle platform. By enabling precise delivery of active compounds, Pnaseer's tech supports various applications, from pharma manufacturing to wellness treatments, while PNAS Therapeutics handles clinical development and commercialization. About is a biotech company using AI and biological data to understand drug-target interactions in disease pathways. Through its AI platform and compound libraries, identifies promising therapeutic molecules and optimizes them for effectiveness. Using advanced machine learning techniques, accelerates the discovery of next-generation treatments for cancer and chronic diseases. View source version on Contacts For media inquiries: Quynh NguyenSenior AI Partnership ManagerEmail: quynh@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data